All In Biotech

Drug Trial Radar · NCT06454708

Pharmacokinetics, Safety and Tolerability of Clascoterone Cream 1% in Healthy Chinese Adult Subjects

An Open Phase I Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Single Dose and Repeat Dose Topical Administrations of Clascoterone Cream, 1% in Healthy Chinese Adult Subjects

Last checked: Nov 20, 2026Latest source record: Jan 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

12

Actual

Start

Aug 1, 2024

Primary completion

Aug 12, 2024

Study completion Aug 12, 2024

Sponsor

Sponsor type
Industry
First posted
Jun 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of this study is to determine the pharmacokinetics (PK) of Clascoterone Cream, 1% after single dose and repeat dose topical administrations in healthy Chinese adult subjects.

Conditions

  • Acne Vulgaris

Interventions

  • Clascoterone Cream 1%Drug

    Clascoterone Cream 1% (Winlevi) is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to maximum plasma concentration (Tmax)Time frame: Day 1
  2. Maximum plasma concentration (Cmax)Time frame: Day 1
  3. Area under the plasma concentration-time curve from time 0 to last time of quantifiable concentration (AUC0-t)Time frame: Day 1
  4. Time to maximum plasma concentration (Tmax)Time frame: Day 7
  5. Maximum plasma concentration at steady state (Cmax,ss)Time frame: Day 7
  6. Minimum plasma concentration at steady state (Cmin,ss)Time frame: Day 7

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Huashan Hospital, Fudan University

    London, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.